Royalty Pharma
RPRX
#814
Rank
A$41.85 B
Marketcap
A$72.69
Share price
-1.48%
Change (1 day)
36.88%
Change (1 year)

Market capitalization of Royalty Pharma (RPRX)

Market cap: A$41.85 Billion

As of May 2026 Royalty Pharma has a market cap of A$41.85 Billion. This makes Royalty Pharma the world's 814th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Royalty Pharma from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026A$41.85 B22.58%
2025A$34.14 B41.15%
2024A$24.19 B-2.14%
2023A$24.72 B-3.5%
2022A$25.61 B8.51%
2021A$23.60 B-6.55%
2020A$25.26 B

End of Day market cap according to different sources

On May 17th, 2026 the market cap of Royalty Pharma was reported to be:

A$42.48 Billion
by Nasdaq info icon info icon
A$42.48 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Abbott Laboratories
ABT
A$213.75 B 410.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$1.230 T 2,838.68%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
A$2.51 B-93.98%๐Ÿ‡บ๐Ÿ‡ธ USA